Global Anti-Malarial Drug Market Growth 2025-2031
The global Anti-Malarial Drug market size is predicted to grow from US$ 719 million in 2025 to US$ 843 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Malarial Drug Industry Forecast? looks at past sales and reviews total world Anti-Malarial Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Malarial Drug sales for 2025 through 2031. With Anti-Malarial Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Malarial Drug industry.
This Insight Report provides a comprehensive analysis of the global Anti-Malarial Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Malarial Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Malarial Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Malarial Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Malarial Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Malarial Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Malarial Drug market?
What factors are driving Anti-Malarial Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Malarial Drug market opportunities vary by end market size?
How does Anti-Malarial Drug break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?Anti-Malarial Drug Industry Forecast? looks at past sales and reviews total world Anti-Malarial Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Malarial Drug sales for 2025 through 2031. With Anti-Malarial Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Malarial Drug industry.
This Insight Report provides a comprehensive analysis of the global Anti-Malarial Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Malarial Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-Malarial Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Malarial Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Malarial Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Malarial Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Plasmodium Falciparum
- Plasmodium Vivax
- Plasmodium Malariae
- Plasmodium Ovale
- Hospital Pharmacy
- Retail Pharmacy
- E-Commerce
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Ranbaxy
- Zydus Cadila
- Alvizia
- Bayer
- Ipca
- Merck
- F. Hoffmann-La Roche
- Novartis
- Pfizer
What is the 10-year outlook for the global Anti-Malarial Drug market?
What factors are driving Anti-Malarial Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Malarial Drug market opportunities vary by end market size?
How does Anti-Malarial Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Malarial Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Malarial Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Malarial Drug by Country/Region, 2020, 2024 & 2031
2.2 Anti-Malarial Drug Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Vivax
2.2.3 Plasmodium Malariae
2.2.4 Plasmodium Ovale
2.3 Anti-Malarial Drug Sales by Type
2.3.1 Global Anti-Malarial Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Malarial Drug Sale Price by Type (2020-2025)
2.4 Anti-Malarial Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-Commerce
2.4.4 Others
2.5 Anti-Malarial Drug Sales by Application
2.5.1 Global Anti-Malarial Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Malarial Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Malarial Drug Breakdown Data by Company
3.1.1 Global Anti-Malarial Drug Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Malarial Drug Sales Market Share by Company (2020-2025)
3.2 Global Anti-Malarial Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Malarial Drug Revenue by Company (2020-2025)
3.2.2 Global Anti-Malarial Drug Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Malarial Drug Sale Price by Company
3.4 Key Manufacturers Anti-Malarial Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Malarial Drug Product Location Distribution
3.4.2 Players Anti-Malarial Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-MALARIAL DRUG BY GEOGRAPHIC REGION
4.1 World Historic Anti-Malarial Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Malarial Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Malarial Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Malarial Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Malarial Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Malarial Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Malarial Drug Sales Growth
4.4 APAC Anti-Malarial Drug Sales Growth
4.5 Europe Anti-Malarial Drug Sales Growth
4.6 Middle East & Africa Anti-Malarial Drug Sales Growth
5 AMERICAS
5.1 Americas Anti-Malarial Drug Sales by Country
5.1.1 Americas Anti-Malarial Drug Sales by Country (2020-2025)
5.1.2 Americas Anti-Malarial Drug Revenue by Country (2020-2025)
5.2 Americas Anti-Malarial Drug Sales by Type (2020-2025)
5.3 Americas Anti-Malarial Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Malarial Drug Sales by Region
6.1.1 APAC Anti-Malarial Drug Sales by Region (2020-2025)
6.1.2 APAC Anti-Malarial Drug Revenue by Region (2020-2025)
6.2 APAC Anti-Malarial Drug Sales by Type (2020-2025)
6.3 APAC Anti-Malarial Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Malarial Drug by Country
7.1.1 Europe Anti-Malarial Drug Sales by Country (2020-2025)
7.1.2 Europe Anti-Malarial Drug Revenue by Country (2020-2025)
7.2 Europe Anti-Malarial Drug Sales by Type (2020-2025)
7.3 Europe Anti-Malarial Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Malarial Drug by Country
8.1.1 Middle East & Africa Anti-Malarial Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Malarial Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Malarial Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Malarial Drug
10.3 Manufacturing Process Analysis of Anti-Malarial Drug
10.4 Industry Chain Structure of Anti-Malarial Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Malarial Drug Distributors
11.3 Anti-Malarial Drug Customer
12 WORLD FORECAST REVIEW FOR ANTI-MALARIAL DRUG BY GEOGRAPHIC REGION
12.1 Global Anti-Malarial Drug Market Size Forecast by Region
12.1.1 Global Anti-Malarial Drug Forecast by Region (2026-2031)
12.1.2 Global Anti-Malarial Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Malarial Drug Forecast by Type (2026-2031)
12.7 Global Anti-Malarial Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Anti-Malarial Drug Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Ranbaxy
13.2.1 Ranbaxy Company Information
13.2.2 Ranbaxy Anti-Malarial Drug Product Portfolios and Specifications
13.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ranbaxy Main Business Overview
13.2.5 Ranbaxy Latest Developments
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Information
13.3.2 Zydus Cadila Anti-Malarial Drug Product Portfolios and Specifications
13.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zydus Cadila Main Business Overview
13.3.5 Zydus Cadila Latest Developments
13.4 Alvizia
13.4.1 Alvizia Company Information
13.4.2 Alvizia Anti-Malarial Drug Product Portfolios and Specifications
13.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Alvizia Main Business Overview
13.4.5 Alvizia Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Anti-Malarial Drug Product Portfolios and Specifications
13.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Ipca
13.6.1 Ipca Company Information
13.6.2 Ipca Anti-Malarial Drug Product Portfolios and Specifications
13.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Main Business Overview
13.6.5 Ipca Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Anti-Malarial Drug Product Portfolios and Specifications
13.7.3 Merck Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Information
13.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolios and Specifications
13.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 F. Hoffmann-La Roche Main Business Overview
13.8.5 F. Hoffmann-La Roche Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Anti-Malarial Drug Product Portfolios and Specifications
13.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Anti-Malarial Drug Product Portfolios and Specifications
13.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Malarial Drug Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Malarial Drug by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Malarial Drug by Country/Region, 2020, 2024 & 2031
2.2 Anti-Malarial Drug Segment by Type
2.2.1 Plasmodium Falciparum
2.2.2 Plasmodium Vivax
2.2.3 Plasmodium Malariae
2.2.4 Plasmodium Ovale
2.3 Anti-Malarial Drug Sales by Type
2.3.1 Global Anti-Malarial Drug Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Malarial Drug Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Malarial Drug Sale Price by Type (2020-2025)
2.4 Anti-Malarial Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 E-Commerce
2.4.4 Others
2.5 Anti-Malarial Drug Sales by Application
2.5.1 Global Anti-Malarial Drug Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Malarial Drug Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Malarial Drug Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Malarial Drug Breakdown Data by Company
3.1.1 Global Anti-Malarial Drug Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Malarial Drug Sales Market Share by Company (2020-2025)
3.2 Global Anti-Malarial Drug Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Malarial Drug Revenue by Company (2020-2025)
3.2.2 Global Anti-Malarial Drug Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Malarial Drug Sale Price by Company
3.4 Key Manufacturers Anti-Malarial Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Malarial Drug Product Location Distribution
3.4.2 Players Anti-Malarial Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-MALARIAL DRUG BY GEOGRAPHIC REGION
4.1 World Historic Anti-Malarial Drug Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Malarial Drug Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Malarial Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Malarial Drug Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Malarial Drug Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Malarial Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Malarial Drug Sales Growth
4.4 APAC Anti-Malarial Drug Sales Growth
4.5 Europe Anti-Malarial Drug Sales Growth
4.6 Middle East & Africa Anti-Malarial Drug Sales Growth
5 AMERICAS
5.1 Americas Anti-Malarial Drug Sales by Country
5.1.1 Americas Anti-Malarial Drug Sales by Country (2020-2025)
5.1.2 Americas Anti-Malarial Drug Revenue by Country (2020-2025)
5.2 Americas Anti-Malarial Drug Sales by Type (2020-2025)
5.3 Americas Anti-Malarial Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Malarial Drug Sales by Region
6.1.1 APAC Anti-Malarial Drug Sales by Region (2020-2025)
6.1.2 APAC Anti-Malarial Drug Revenue by Region (2020-2025)
6.2 APAC Anti-Malarial Drug Sales by Type (2020-2025)
6.3 APAC Anti-Malarial Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Malarial Drug by Country
7.1.1 Europe Anti-Malarial Drug Sales by Country (2020-2025)
7.1.2 Europe Anti-Malarial Drug Revenue by Country (2020-2025)
7.2 Europe Anti-Malarial Drug Sales by Type (2020-2025)
7.3 Europe Anti-Malarial Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Malarial Drug by Country
8.1.1 Middle East & Africa Anti-Malarial Drug Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Malarial Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Malarial Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Malarial Drug
10.3 Manufacturing Process Analysis of Anti-Malarial Drug
10.4 Industry Chain Structure of Anti-Malarial Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Malarial Drug Distributors
11.3 Anti-Malarial Drug Customer
12 WORLD FORECAST REVIEW FOR ANTI-MALARIAL DRUG BY GEOGRAPHIC REGION
12.1 Global Anti-Malarial Drug Market Size Forecast by Region
12.1.1 Global Anti-Malarial Drug Forecast by Region (2026-2031)
12.1.2 Global Anti-Malarial Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Malarial Drug Forecast by Type (2026-2031)
12.7 Global Anti-Malarial Drug Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Anti-Malarial Drug Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Ranbaxy
13.2.1 Ranbaxy Company Information
13.2.2 Ranbaxy Anti-Malarial Drug Product Portfolios and Specifications
13.2.3 Ranbaxy Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Ranbaxy Main Business Overview
13.2.5 Ranbaxy Latest Developments
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Information
13.3.2 Zydus Cadila Anti-Malarial Drug Product Portfolios and Specifications
13.3.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Zydus Cadila Main Business Overview
13.3.5 Zydus Cadila Latest Developments
13.4 Alvizia
13.4.1 Alvizia Company Information
13.4.2 Alvizia Anti-Malarial Drug Product Portfolios and Specifications
13.4.3 Alvizia Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Alvizia Main Business Overview
13.4.5 Alvizia Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Anti-Malarial Drug Product Portfolios and Specifications
13.5.3 Bayer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Ipca
13.6.1 Ipca Company Information
13.6.2 Ipca Anti-Malarial Drug Product Portfolios and Specifications
13.6.3 Ipca Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Main Business Overview
13.6.5 Ipca Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Anti-Malarial Drug Product Portfolios and Specifications
13.7.3 Merck Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 F. Hoffmann-La Roche
13.8.1 F. Hoffmann-La Roche Company Information
13.8.2 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolios and Specifications
13.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 F. Hoffmann-La Roche Main Business Overview
13.8.5 F. Hoffmann-La Roche Latest Developments
13.9 Novartis
13.9.1 Novartis Company Information
13.9.2 Novartis Anti-Malarial Drug Product Portfolios and Specifications
13.9.3 Novartis Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Novartis Main Business Overview
13.9.5 Novartis Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Anti-Malarial Drug Product Portfolios and Specifications
13.10.3 Pfizer Anti-Malarial Drug Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Malarial Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Malarial Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmodium Falciparum
Table 4. Major Players of Plasmodium Vivax
Table 5. Major Players of Plasmodium Malariae
Table 6. Major Players of Plasmodium Ovale
Table 7. Global Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 8. Global Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Table 9. Global Anti-Malarial Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Anti-Malarial Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Anti-Malarial Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Anti-Malarial Drug Sale by Application (2020-2025) & (Units)
Table 13. Global Anti-Malarial Drug Sale Market Share by Application (2020-2025)
Table 14. Global Anti-Malarial Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-Malarial Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-Malarial Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Anti-Malarial Drug Sales by Company (2020-2025) & (Units)
Table 18. Global Anti-Malarial Drug Sales Market Share by Company (2020-2025)
Table 19. Global Anti-Malarial Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-Malarial Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-Malarial Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Anti-Malarial Drug Producing Area Distribution and Sales Area
Table 23. Players Anti-Malarial Drug Products Offered
Table 24. Anti-Malarial Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-Malarial Drug Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Anti-Malarial Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-Malarial Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-Malarial Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-Malarial Drug Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Anti-Malarial Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-Malarial Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-Malarial Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 36. Americas Anti-Malarial Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-Malarial Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 39. Americas Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 40. APAC Anti-Malarial Drug Sales by Region (2020-2025) & (Units)
Table 41. APAC Anti-Malarial Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-Malarial Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 44. APAC Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 45. Europe Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 46. Europe Anti-Malarial Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 48. Europe Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 52. Middle East & Africa Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-Malarial Drug
Table 54. Key Market Challenges & Risks of Anti-Malarial Drug
Table 55. Key Industry Trends of Anti-Malarial Drug
Table 56. Anti-Malarial Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-Malarial Drug Distributors List
Table 59. Anti-Malarial Drug Customer List
Table 60. Global Anti-Malarial Drug Sales Forecast by Region (2026-2031) & (Units)
Table 61. Global Anti-Malarial Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 63. Americas Anti-Malarial Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-Malarial Drug Sales Forecast by Region (2026-2031) & (Units)
Table 65. APAC Anti-Malarial Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 67. Europe Anti-Malarial Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Anti-Malarial Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-Malarial Drug Sales Forecast by Type (2026-2031) & (Units)
Table 71. Global Anti-Malarial Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Anti-Malarial Drug Sales Forecast by Application (2026-2031) & (Units)
Table 73. Global Anti-Malarial Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. GlaxoSmithKline Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. GlaxoSmithKline Anti-Malarial Drug Product Portfolios and Specifications
Table 76. GlaxoSmithKline Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. Ranbaxy Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Ranbaxy Anti-Malarial Drug Product Portfolios and Specifications
Table 81. Ranbaxy Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Ranbaxy Main Business
Table 83. Ranbaxy Latest Developments
Table 84. Zydus Cadila Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Zydus Cadila Anti-Malarial Drug Product Portfolios and Specifications
Table 86. Zydus Cadila Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Zydus Cadila Main Business
Table 88. Zydus Cadila Latest Developments
Table 89. Alvizia Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Alvizia Anti-Malarial Drug Product Portfolios and Specifications
Table 91. Alvizia Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Alvizia Main Business
Table 93. Alvizia Latest Developments
Table 94. Bayer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Anti-Malarial Drug Product Portfolios and Specifications
Table 96. Bayer Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Ipca Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Ipca Anti-Malarial Drug Product Portfolios and Specifications
Table 101. Ipca Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Ipca Main Business
Table 103. Ipca Latest Developments
Table 104. Merck Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Anti-Malarial Drug Product Portfolios and Specifications
Table 106. Merck Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. F. Hoffmann-La Roche Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolios and Specifications
Table 111. F. Hoffmann-La Roche Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. F. Hoffmann-La Roche Main Business
Table 113. F. Hoffmann-La Roche Latest Developments
Table 114. Novartis Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis Anti-Malarial Drug Product Portfolios and Specifications
Table 116. Novartis Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Novartis Main Business
Table 118. Novartis Latest Developments
Table 119. Pfizer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Anti-Malarial Drug Product Portfolios and Specifications
Table 121. Pfizer Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 1. Anti-Malarial Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Malarial Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Plasmodium Falciparum
Table 4. Major Players of Plasmodium Vivax
Table 5. Major Players of Plasmodium Malariae
Table 6. Major Players of Plasmodium Ovale
Table 7. Global Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 8. Global Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Table 9. Global Anti-Malarial Drug Revenue by Type (2020-2025) & ($ million)
Table 10. Global Anti-Malarial Drug Revenue Market Share by Type (2020-2025)
Table 11. Global Anti-Malarial Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Anti-Malarial Drug Sale by Application (2020-2025) & (Units)
Table 13. Global Anti-Malarial Drug Sale Market Share by Application (2020-2025)
Table 14. Global Anti-Malarial Drug Revenue by Application (2020-2025) & ($ million)
Table 15. Global Anti-Malarial Drug Revenue Market Share by Application (2020-2025)
Table 16. Global Anti-Malarial Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Anti-Malarial Drug Sales by Company (2020-2025) & (Units)
Table 18. Global Anti-Malarial Drug Sales Market Share by Company (2020-2025)
Table 19. Global Anti-Malarial Drug Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Anti-Malarial Drug Revenue Market Share by Company (2020-2025)
Table 21. Global Anti-Malarial Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Anti-Malarial Drug Producing Area Distribution and Sales Area
Table 23. Players Anti-Malarial Drug Products Offered
Table 24. Anti-Malarial Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-Malarial Drug Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Anti-Malarial Drug Sales Market Share Geographic Region (2020-2025)
Table 29. Global Anti-Malarial Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Anti-Malarial Drug Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Anti-Malarial Drug Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Anti-Malarial Drug Sales Market Share by Country/Region (2020-2025)
Table 33. Global Anti-Malarial Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Anti-Malarial Drug Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 36. Americas Anti-Malarial Drug Sales Market Share by Country (2020-2025)
Table 37. Americas Anti-Malarial Drug Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 39. Americas Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 40. APAC Anti-Malarial Drug Sales by Region (2020-2025) & (Units)
Table 41. APAC Anti-Malarial Drug Sales Market Share by Region (2020-2025)
Table 42. APAC Anti-Malarial Drug Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 44. APAC Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 45. Europe Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 46. Europe Anti-Malarial Drug Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 48. Europe Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Anti-Malarial Drug Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Anti-Malarial Drug Sales by Type (2020-2025) & (Units)
Table 52. Middle East & Africa Anti-Malarial Drug Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-Malarial Drug
Table 54. Key Market Challenges & Risks of Anti-Malarial Drug
Table 55. Key Industry Trends of Anti-Malarial Drug
Table 56. Anti-Malarial Drug Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-Malarial Drug Distributors List
Table 59. Anti-Malarial Drug Customer List
Table 60. Global Anti-Malarial Drug Sales Forecast by Region (2026-2031) & (Units)
Table 61. Global Anti-Malarial Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 63. Americas Anti-Malarial Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Anti-Malarial Drug Sales Forecast by Region (2026-2031) & (Units)
Table 65. APAC Anti-Malarial Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 67. Europe Anti-Malarial Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Anti-Malarial Drug Sales Forecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Anti-Malarial Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Anti-Malarial Drug Sales Forecast by Type (2026-2031) & (Units)
Table 71. Global Anti-Malarial Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Anti-Malarial Drug Sales Forecast by Application (2026-2031) & (Units)
Table 73. Global Anti-Malarial Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. GlaxoSmithKline Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 75. GlaxoSmithKline Anti-Malarial Drug Product Portfolios and Specifications
Table 76. GlaxoSmithKline Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GlaxoSmithKline Main Business
Table 78. GlaxoSmithKline Latest Developments
Table 79. Ranbaxy Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Ranbaxy Anti-Malarial Drug Product Portfolios and Specifications
Table 81. Ranbaxy Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Ranbaxy Main Business
Table 83. Ranbaxy Latest Developments
Table 84. Zydus Cadila Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Zydus Cadila Anti-Malarial Drug Product Portfolios and Specifications
Table 86. Zydus Cadila Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Zydus Cadila Main Business
Table 88. Zydus Cadila Latest Developments
Table 89. Alvizia Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Alvizia Anti-Malarial Drug Product Portfolios and Specifications
Table 91. Alvizia Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Alvizia Main Business
Table 93. Alvizia Latest Developments
Table 94. Bayer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Anti-Malarial Drug Product Portfolios and Specifications
Table 96. Bayer Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Ipca Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Ipca Anti-Malarial Drug Product Portfolios and Specifications
Table 101. Ipca Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Ipca Main Business
Table 103. Ipca Latest Developments
Table 104. Merck Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Anti-Malarial Drug Product Portfolios and Specifications
Table 106. Merck Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. F. Hoffmann-La Roche Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolios and Specifications
Table 111. F. Hoffmann-La Roche Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. F. Hoffmann-La Roche Main Business
Table 113. F. Hoffmann-La Roche Latest Developments
Table 114. Novartis Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis Anti-Malarial Drug Product Portfolios and Specifications
Table 116. Novartis Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Novartis Main Business
Table 118. Novartis Latest Developments
Table 119. Pfizer Basic Information, Anti-Malarial Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Anti-Malarial Drug Product Portfolios and Specifications
Table 121. Pfizer Anti-Malarial Drug Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Malarial Drug
Figure 2. Anti-Malarial Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Malarial Drug Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Anti-Malarial Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Malarial Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Malarial Drug Sales Market Share by Country/Region (2024)
Figure 10. Anti-Malarial Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plasmodium Falciparum
Figure 12. Product Picture of Plasmodium Vivax
Figure 13. Product Picture of Plasmodium Malariae
Figure 14. Product Picture of Plasmodium Ovale
Figure 15. Global Anti-Malarial Drug Sales Market Share by Type in 2025
Figure 16. Global Anti-Malarial Drug Revenue Market Share by Type (2020-2025)
Figure 17. Anti-Malarial Drug Consumed in Hospital Pharmacy
Figure 18. Global Anti-Malarial Drug Market: Hospital Pharmacy (2020-2025) & (Units)
Figure 19. Anti-Malarial Drug Consumed in Retail Pharmacy
Figure 20. Global Anti-Malarial Drug Market: Retail Pharmacy (2020-2025) & (Units)
Figure 21. Anti-Malarial Drug Consumed in E-Commerce
Figure 22. Global Anti-Malarial Drug Market: E-Commerce (2020-2025) & (Units)
Figure 23. Anti-Malarial Drug Consumed in Others
Figure 24. Global Anti-Malarial Drug Market: Others (2020-2025) & (Units)
Figure 25. Global Anti-Malarial Drug Sale Market Share by Application (2024)
Figure 26. Global Anti-Malarial Drug Revenue Market Share by Application in 2025
Figure 27. Anti-Malarial Drug Sales by Company in 2025 (Units)
Figure 28. Global Anti-Malarial Drug Sales Market Share by Company in 2025
Figure 29. Anti-Malarial Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-Malarial Drug Revenue Market Share by Company in 2025
Figure 31. Global Anti-Malarial Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-Malarial Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 34. Americas Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 36. APAC Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 38. Europe Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 40. Middle East & Africa Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-Malarial Drug Sales Market Share by Country in 2025
Figure 42. Americas Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 44. Americas Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-Malarial Drug Sales Market Share by Region in 2025
Figure 50. APAC Anti-Malarial Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 52. APAC Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 53. China Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-Malarial Drug Sales Market Share by Country in 2025
Figure 61. Europe Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 63. Europe Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. France Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-Malarial Drug in 2025
Figure 78. Manufacturing Process Analysis of Anti-Malarial Drug
Figure 79. Industry Chain Structure of Anti-Malarial Drug
Figure 80. Channels of Distribution
Figure 81. Global Anti-Malarial Drug Sales Market Forecast by Region (2026-2031)
Figure 82. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-Malarial Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Anti-Malarial Drug Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Anti-Malarial Drug Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Anti-Malarial Drug
Figure 2. Anti-Malarial Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Malarial Drug Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Anti-Malarial Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Malarial Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Malarial Drug Sales Market Share by Country/Region (2024)
Figure 10. Anti-Malarial Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Plasmodium Falciparum
Figure 12. Product Picture of Plasmodium Vivax
Figure 13. Product Picture of Plasmodium Malariae
Figure 14. Product Picture of Plasmodium Ovale
Figure 15. Global Anti-Malarial Drug Sales Market Share by Type in 2025
Figure 16. Global Anti-Malarial Drug Revenue Market Share by Type (2020-2025)
Figure 17. Anti-Malarial Drug Consumed in Hospital Pharmacy
Figure 18. Global Anti-Malarial Drug Market: Hospital Pharmacy (2020-2025) & (Units)
Figure 19. Anti-Malarial Drug Consumed in Retail Pharmacy
Figure 20. Global Anti-Malarial Drug Market: Retail Pharmacy (2020-2025) & (Units)
Figure 21. Anti-Malarial Drug Consumed in E-Commerce
Figure 22. Global Anti-Malarial Drug Market: E-Commerce (2020-2025) & (Units)
Figure 23. Anti-Malarial Drug Consumed in Others
Figure 24. Global Anti-Malarial Drug Market: Others (2020-2025) & (Units)
Figure 25. Global Anti-Malarial Drug Sale Market Share by Application (2024)
Figure 26. Global Anti-Malarial Drug Revenue Market Share by Application in 2025
Figure 27. Anti-Malarial Drug Sales by Company in 2025 (Units)
Figure 28. Global Anti-Malarial Drug Sales Market Share by Company in 2025
Figure 29. Anti-Malarial Drug Revenue by Company in 2025 ($ millions)
Figure 30. Global Anti-Malarial Drug Revenue Market Share by Company in 2025
Figure 31. Global Anti-Malarial Drug Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Anti-Malarial Drug Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 34. Americas Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 35. APAC Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 36. APAC Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 37. Europe Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 38. Europe Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Anti-Malarial Drug Sales 2020-2025 (Units)
Figure 40. Middle East & Africa Anti-Malarial Drug Revenue 2020-2025 ($ millions)
Figure 41. Americas Anti-Malarial Drug Sales Market Share by Country in 2025
Figure 42. Americas Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Figure 43. Americas Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 44. Americas Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 45. United States Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Anti-Malarial Drug Sales Market Share by Region in 2025
Figure 50. APAC Anti-Malarial Drug Revenue Market Share by Region (2020-2025)
Figure 51. APAC Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 52. APAC Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 53. China Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. India Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Anti-Malarial Drug Sales Market Share by Country in 2025
Figure 61. Europe Anti-Malarial Drug Revenue Market Share by Country (2020-2025)
Figure 62. Europe Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 63. Europe Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 64. Germany Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 65. France Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Anti-Malarial Drug Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2020-2025)
Figure 72. Egypt Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Anti-Malarial Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Anti-Malarial Drug in 2025
Figure 78. Manufacturing Process Analysis of Anti-Malarial Drug
Figure 79. Industry Chain Structure of Anti-Malarial Drug
Figure 80. Channels of Distribution
Figure 81. Global Anti-Malarial Drug Sales Market Forecast by Region (2026-2031)
Figure 82. Global Anti-Malarial Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Anti-Malarial Drug Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Anti-Malarial Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Anti-Malarial Drug Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Anti-Malarial Drug Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Mobile Computerized Tomography (CT) Market Growth 2024-2030
US$ 3,660.00
June 2024
111 pages
Global Grape Seed Extract Supplements Market Growth 2023-2029
US$ 3,660.00
March 2023
102 pages
Global End Stage Renal Disease Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
83 pages
Global Female Urinary Incontinence Products Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
124 pages
Global Robot-Assisted Surgery System Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
124 pages
